This topic contains a solution. Click here to go to the answer

Author Question: Autoantibodies against parietal cells and intrinsic factor are associated with: a. Grave's ... (Read 92 times)

Sufayan.ah

  • Hero Member
  • *****
  • Posts: 512
Autoantibodies against parietal cells and intrinsic factor are associated with:
 
  a. Grave's disease
  b. Hashimoto's thyroiditis
  c. Addison's disease
  d. Pernicious anemia

Question 2

Which of the following are key features found in nonmegaloblastic macrocytosis?
 
  a. Oval red blood cells
  b. Hypersegmented neutrophils
  c. Jaundice, glossitis, and neuropathy
  d. Round macrocytes



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Galvarado142

  • Sr. Member
  • ****
  • Posts: 348
Answer to Question 1

Correct Answer: D

Answer to Question 2

Correct Answer: D




Sufayan.ah

  • Member
  • Posts: 512
Reply 2 on: Jun 25, 2018
Gracias!


okolip

  • Member
  • Posts: 362
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The term bacteria was devised in the 19th century by German biologist Ferdinand Cohn. He based it on the Greek word "bakterion" meaning a small rod or staff. Cohn is considered to be the father of modern bacteriology.

Did you know?

To combat osteoporosis, changes in lifestyle and diet are recommended. At-risk patients should include 1,200 to 1,500 mg of calcium daily either via dietary means or with supplements.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

Patients who have been on total parenteral nutrition for more than a few days may need to have foods gradually reintroduced to give the digestive tract time to start working again.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library